47 related articles for article (PubMed ID: 38622518)
1. SKA3/PTTG1/c-MYC signal loop drives the progression of colorectal cancer.
Zhang H; Chang Z; Wang C; Yuan Z; Liu Y; Wang Y; Zhang W; Zhong Y; Wang M; Zou C; Tang Q; Hu H; Wang G
Clin Transl Med; 2024 Jun; 14(6):e1730. PubMed ID: 38849978
[No Abstract] [Full Text] [Related]
2. MYC and integrins interplay in colorectal cancer.
Boudjadi S; Beaulieu JF
Oncoscience; 2016; 3(2):50-1. PubMed ID: 27014720
[No Abstract] [Full Text] [Related]
3. The life cycle of C-myc: from synthesis to degradation.
Sears RC
Cell Cycle; 2004 Sep; 3(9):1133-7. PubMed ID: 15467447
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
5. STK16 promoted colorectal cancer progress in a c-MYC signaling-dependent manner.
Peng L; Guangshi L; Wusman LB; Tao L
Mol Med; 2024 Apr; 30(1):50. PubMed ID: 38622518
[TBL] [Abstract][Full Text] [Related]
6. SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
Shen Z; Li Y; Fang Y; Lin M; Feng X; Li Z; Zhan Y; Liu Y; Mou T; Lan X; Wang Y; Li G; Wang J; Deng H
Mol Oncol; 2020 Feb; 14(2):387-406. PubMed ID: 31876369
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
8. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
9. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
[TBL] [Abstract][Full Text] [Related]
10. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.
Wang X; Huang R; Lu Z; Wang Z; Chen X; Huang D
Cancer Sci; 2022 Mar; 113(3):986-1001. PubMed ID: 35092121
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of "undruggable" MYC.
Llombart V; Mansour MR
EBioMedicine; 2022 Jan; 75():103756. PubMed ID: 34942444
[TBL] [Abstract][Full Text] [Related]
13. Tilting MYC toward cancer cell death.
Harrington CT; Sotillo E; Dang CV; Thomas-Tikhonenko A
Trends Cancer; 2021 Nov; 7(11):982-994. PubMed ID: 34481764
[TBL] [Abstract][Full Text] [Related]
14. MYC as a target for cancer treatment.
Duffy MJ; O'Grady S; Tang M; Crown J
Cancer Treat Rev; 2021 Mar; 94():102154. PubMed ID: 33524794
[TBL] [Abstract][Full Text] [Related]
15. A kinase cascade on the yeast lysosomal vacuole regulates its membrane dynamics: conserved kinase Env7 is phosphorylated by casein kinase Yck3.
Manandhar SP; Siddiqah IM; Cocca SM; Gharakhanian E
J Biol Chem; 2020 Aug; 295(34):12262-12278. PubMed ID: 32647006
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
